Mainz Biomed N.V.
MYNZ
$1.59
-$0.02-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -44.93% | -44.93% | -13.13% | 4.62% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -44.93% | -44.93% | -13.13% | 4.62% | |
| Cost of Revenue | -51.83% | -51.83% | -26.63% | 0.80% | |
| Gross Profit | -40.56% | -40.56% | -5.05% | 7.19% | |
| SG&A Expenses | -24.09% | -24.09% | -33.66% | -30.66% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -18.88% | -18.88% | -33.99% | -36.83% | |
| Operating Income | 17.50% | 17.50% | 34.67% | 38.13% | |
| Income Before Tax | 24.31% | 24.31% | -2.51% | 33.20% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 24.31% | 24.31% | -2.51% | 33.20% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 24.31% | 24.31% | -2.51% | 33.20% | |
| EBIT | 17.50% | 17.50% | 34.67% | 38.13% | |
| EBITDA | 16.83% | 16.83% | 34.76% | 40.95% | |
| EPS Basic | 86.55% | 86.55% | 64.49% | 55.42% | |
| Normalized Basic EPS | 85.84% | 85.84% | 73.98% | -- | |
| EPS Diluted | 86.55% | 86.55% | 64.49% | 55.42% | |
| Normalized Diluted EPS | 85.84% | 85.84% | 73.98% | -- | |
| Average Basic Shares Outstanding | 462.71% | 462.71% | 188.70% | 49.85% | |
| Average Diluted Shares Outstanding | 462.71% | 462.71% | 188.70% | 49.85% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |